Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Melanoma 1Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Epstein-Barr Virus Infections 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Rituximab 4Valganciclovir 2Valacyclovir 2Carboplatin 2Acyclovir 2valomaciclovir 1threonic acid 1otelixizumab 1cc-486 1Zidovudine 1Vincristine 1Vaccines 1Tomography, X-Ray Computed 1Prednisone 1Polymerase Chain Reaction 1Methotrexate 1Matrix-M 1Magnesium Sulfate 1MVA vaccine 1Leucovorin 1Kidney Transplantation 1Interferons 1In Situ Hybridization 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Gene-Eden-VIR 1Gastrectomy 1Flow Cytometry 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Epstein-Barr Virus Infections × In Situ Hybridization × Clear all
NCT01490801 2016-05-17

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Children's Oncology Group

Completed
50 enrolled
LymphoidMyeloid

Hodgkin Disease, Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡